Stryker SYK
Stryker is a medical device multinational that designs and sells orthopedic implants, surgical equipment, and technologies for medical procedures, generating recurring revenue from the sale of consumables and services. Stryker shows solid financial health (score 7.63) and 44.1% earnings growth, but its valuation (P/E 28.25) and low momentum (score 3.63) limit short-term appeal.
Detailed metrics
Market and fundamental data as of the analysis date.
Full AI report
Generated automatically from the metrics, the macro context and the company's news.
Stryker is a medical device multinational that designs and sells orthopedic implants, surgical equipment, and technologies for medical procedures, generating recurring revenue from the sale of consumables and services. Stryker shows solid financial health (score 7.63) and 44.1% earnings growth, but its valuation (P/E 28.25) and low momentum (score 3.63) limit short-term appeal.
Score by category
| Category | Score |
|---|---|
| Financial health | 7.6 |
| Quality / Moat | 7.3 |
| Valuation | 5.3 |
| Growth | 7.8 |
| Dividend | 5.9 |
| Momentum | 3.6 |
| Risk & Context | 7.5 |
OVERALL SCORE: 6.6/10
Context and risks
No material exposure to highlighted macro factors. The medical devices business does not depend on oil prices, 10-year Treasury yields do not affect its demand, and there is no direct geopolitical risk in its supply chain or main markets.
News considered in the analysis
- Can This Number Push ISRG Stock Higher? — Artículo de análisis sobre Intuitive Surgical, no aporta información nueva sobre Stryker.
- What Does General Dynamics (GD) Winning New Stryker Work Mean Through 2028? — Titular engañoso: se refiere al vehículo blindado Stryker de General Dynamics, no a la empresa de dispositivos médicos. Sin relevancia.
- Intuitive Surgical vs. Stryker: Which MedTech Stock Is the Better Buy Now? — Comparativa genérica de Zacks sin información específica o nueva sobre Stryker.
- Can Stryker Vehicle Demand Support General Dynamics' Growth? — Titular confuso que mezcla el nombre de la empresa con el vehículo blindado. Sin información relevante para Stryker Corporation.
- Here's Why You Should Hold Stryker Stock in Your Portfolio for Now — Opinión de analista de Zacks sin datos concretos o catalizadores específicos. Ruido.
Verdict: Hold: fundamentals are solid, but the current price does not offer a sufficient margin of safety.
Main risk: The main risk is a slowdown in demand for elective procedures, which could impact Stryker's recurring revenue growth.
Other Healthcare companies
Neighbours in the sector ranking, to compare without going back to the index.
See all 1,000+ companies in the index →